Skip to main content

NEW YORK (TheStreet) -- Pharmacy stocks are in a healthy position, said Jim Cramer during Monday's segment of CNBC's "Stop Trading" segment. 

Case in point: Rite Aid (RAD) - Get Rite Aid Corporation Report  whose shares continue to climb -- up over 3% Monday -- after reporting a beat on revenue and earnings on Thursday. The company's generic drug reimbursement issues are now behind it and it has done a great job with its store remodelings, explained Cramer, the co-manager of the Action Alerts PLUS portfolio, and he thinks shares can "go much higher." 

Rite Aid RAD data by YCharts

Image placeholder title
Scroll to Continue

TheStreet Recommends

Cramer added Cowen & Company's Charles Rhyee upgraded Rite Aid to outperform from market perform and raised his price target to $8.50 from $6. 

The drugstore industry as a whole remains quite strong, Cramer said. CVS Health (CVS) - Get CVS Health Corporation Report has done a "remarkable job" since eliminating cigarette sales from its locations, he said. Walgreen (WAG) , an AAP holding, reports earnings on Tuesday. 

-- Written by Bret Kenwell

Follow @BretKenwell

At the time of publication, Cramer's Action Alerts PLUS had a position in WAG.